Primer on Tumor Immunology and Biological Therapy of Cancer
October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

Program Schedule
To view slides from a presenter click the
icon next to the presentation title.
Friday, October 1
|
Session I: Basic Tumor Immunology
|
|
8:05 am - 8:50 am |
Innate Immunity and Inflammation
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
|
|
8:50 am - 9:35 am |
Overview of Adaptive Immunity
Emmanuel T. Akporiaye, PhD - Robert Franz Cancer Research Center,
Earle A. Chiles Research Institute
|
|
9:35 am - 10:20 am |
Will Dendritic Cells Help Us Address the Challenge of Cancer Vaccines?
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research |
|
10:35 am - 11:20 am |
Immunotherapeutic Barriers at the Level of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
|
|
11:20 am - 12:05 pm |
Regulatory Immune Cells
James H. Finke, PhD - Cleveland Clinic Foundation
|
|
|
|
Session II: Clinical / Translational Cancer Immunology
|
|
1:00 pm - 1:45 pm |
Immune Monitoring
Lisa H. Butterfield, PhD - University of Pittsburgh
|
|
1:45 pm - 2:30 pm |
Cytokines in Cancer Immunotherapy
Kim A. Margolin, MD - Seattle Cancer Center Alliance
|
|
2:30 pm - 3:15 pm |
Immune Modulating Antibodies
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
|
|
3:30 pm - 4:15 pm |
Cancer Vaccines
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute |
|
4:15 pm - 5:00 pm |
Adoptive T-Cell Therapy
Patrick Hwu, MD - MD Anderson Cancer Center |
|
|
|
Saturday, October 2 - Monday, October 4
|
iSBTc 25th Annual Meeting
For more information, click here. |